Nephros (NEPH) Operating Expenses (2010 - 2026)

Nephros' Operating Expenses history runs 17 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 11.9% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $10.8 million, a 20.96% increase from a year earlier, with the FY2025 full-year figure at $10.5 million, up 20.21% from the prior year.
• Operating Expenses grew to $2.9 million in Q1 2026 per NEPH's latest filing, from $2.7 million in the prior quarter.
• Across five years, Operating Expenses topped out at $2.9 million in Q1 2026 and bottomed at $1.9 million in Q3 2024.
• The 5-year median for Operating Expenses is $2.4 million (2023), against an average of $2.4 million.
• Across the five-year window, Operating Expenses retreated 19.18% in 2024 and soared 33.87% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $2.2 million in 2022, then increased by 21.25% to $2.7 million in 2023, then retreated by 19.18% to $2.2 million in 2024, then climbed by 27.11% to $2.7 million in 2025, then rose by 5.58% to $2.9 million in 2026.
• Per Business Quant, the three latest NEPH Operating Expenses figures stand at $2.9 million (Q1 2026), $2.7 million (Q4 2025), and $2.6 million (Q3 2025).